Commercialization: Page 33
-
PharmaVoice Team/PharmaVoice
Don't Mistake Copy for Content Marketing
More than half — 58% — of the pharma/biotech industry is spending more than $50 million in content development every year, but much of that content is not connected to a solid objective, which means money and time are being wasted. In a recent Accenture study, only 11% of pharma/biotech marketers...
By Robin Robinson • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Social Media
Social Media Trends What’s hot, what’s not, and the analytics driving it all. For the first time, digital and social media ad spending — $72.09 billion — surpassed that of TV — $71.29 billion, according to a recent study from eMarketer. This shift may have marketers everywhere revisiting their st...
By PharmaVoice Team • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Social Media Is Pharma's Key To Reaching Millennials
Millennials? Hmmph. “I’m sick of hearing about them. They’re not driving my business, and I couldn’t care less about them." If you fall into this camp, you’re not reading the tea leaves. Today, the average age of a millennial is 26. They are the largest generation in the United States, at 75.4 mi...
By Joe Youssef • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Ease Your Way Into Social
As the generation marketers have labeled “millennials" mature into their role as heads of family and healthcare consumers, how can modern pharmaceutical brands begin to build a relationship with them? For a generation that has come of age as digital and social media natives, how do we engage with...
By Winnie Tan • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Transcending Traditional Social Media: From Awareness to Uncovering Actionable Insights
It goes without saying that social media is one of the most widely used forms of communication today. Pharmaceutical companies are trying to “crack the code" and understand how to effectively use this channel to achieve organizational initiatives while complying with rigorous industry regulation...
By Dr. Theodore Search • Jan. 1, 2017 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large AbbVie Ireland Takes Efforts to Reduce Carbon Footprint AbbVie’s facility in Sligo, Ireland, was the first of the company’s sites to address how to save energy and reduce its carbon footprint by implementing ISO 50001 standards for improving energy management systems. The progr...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Remote Patient Monitoring Device Market to Reach $1.5 Billion by 2024 Trending Now: From smart bras to inhalers, remote monitoring devices continue to gain traction. Cardiovascular Diseases, Respiratory Disorders, and Diabetes Drive Growth in Global Remote Patient Monitoring Device Market Accord...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Triple Aim
There is a continuing push within the healthcare ecosystem toward patient-centric care, population health, and cost and value. These three areas dramatically impact the industry across myriad operational and executional channels. Triple Aim, an initiative that serves as the foundation for organiz...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Trending 2017: Virtual Reality
What do Pokemon Go, Zombies, Run!, and Excedrin have in common? They are all using augmented or virtual reality to motivate consumers to be more active, or in the case of Excedrin, to be more compassionate. Earlier this year, Excedrin launched the world’s first augmented reality (AR) migraine sim...
By PharmaVoice Team • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: eSolutions
E-Solutions are forever changing the industry. Many of the top 10 trends identified in this issue that are expected to impact the industry in the near- and long-term are based on disruptive technologies and solutions. As Bertalan Mesko, Ph.D., “The Medical Futurist" notes, disruptive technology i...
By Taren Grom • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
It's All Related: Veganism, EHR, and Conversational Marketing
Humans have no need for animal products; the increasing numbers of vegans in this country (and planet), is a testament to how easy it is to live a healthily fulfilling lifestyle without ever harming an animal." This quote by author Angel Finn inspired me to make a change, one my family and I have...
By Angelo Campano • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
If A Picture Is Worth A Thousand Words, Video is Worth A Million
At the heart of every digital trend is a user behavior — video is no different. As humans, we have loved telling stories since the beginning of time. We love telling stories, and hearing them, and there is no better medium for storytelling than video. Proof Is in the Numbers: The Data Support Thi...
By Chris Cullmann • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence and Visual Analytics: Insight From Biomedical Literature is Now in Sight
The importance of the biomedical literature to the pharmaceutical industry cannot be overstated. Understanding the literature is a cornerstone for discovery, publication planning, competitive intelligence, identification of adverse events, compliance, and more. Despite being so essential for the ...
By Jeffrey Saffer • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Overcoming Dual Reimbursement Challenges With Integrated Digital Solutions
Many of us are watching with fascination and concern as payers decide to exit certain markets in 2017, based on the economics of delivering care in specific states. Meanwhile, there’s another payer trend that is just as important for manufacturers to follow closely — payer formulary adoption of p...
By Sandy Piscitello • Nov. 21, 2016 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Clinical Data in Real Time The number of clinical trials using mobile apps more than doubled, rising from 135 in 2014 to 300 in 2015, according to the IMS Health Study Patient Options Expand as Mobile Healthcare Apps Address Wellness and Chronic Disease Treatment Needs. No doubt when 2016 numbers...
By Taren Grom • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Upfront
Industry at Large BMS Employees Cycle Coast to Coast to Raise Money for Cancer Research The first of six teams of Bristol-Myers Squibb oncology employees set out in September from Cannon Beach on the Oregon coast on the first leg of the 2016 Coast 2 Coast 4 Cancer Ride, a 21-day cycling ride that...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth
Novartis Niji System May Provide Earlier Diagnosis of Severe Allergic Asthma Trending Now: Point-of-care testing is gaining significance. Novartis has unveiled a novel in-office point-of-care diagnostic tool: the Niji System and Total IgE Test. This first-ever test delivers quantitative total Ig...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Pharma Trax
High-value Specialty Medicines are Driving Growth in the Generics Market Trending now: Emerging markets are the next big opportunity after the United States. Increased life expectancy, a growing older-population cohort, and the higher incidence of chronic lifestyle-related diseases are encouragi...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Tools of the Trade
Medidata Introduces Payment Technology for Clinical Trial Sites Trending Now: The market’s first end-to-end cloud-based reimbursement tool uses clinical trial data to calculate costs and disburse payment to investigative sites in real time. Medidata has launched Medidata Payments. A new compone...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
What's New
Biomedical Literature Product Released Trending now: AI Platform Forms Basis for Discovery Tool Quertle LLC, a developer of the first artificial intelligence (AI) biomedical big data platform (BioAI), has released Qinsight. The product uses BioAI’s neural networks and other AI methods, along with...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Calendar
Coming Attractions The Global Site Solutions Summit, produced by the Society for Clinical Research Sites (SCRS), is committed to being “the site’s meeting." The conference provides a unique hub where sites, sponsors, CRO executives, and regulators come together and share best practices; build the...
By PharmaVoice Team • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Last Word
Providing Global Access Isabel Torres, Global Head, Access to Medicines Initiative, Takeda, talks about the company’s strategy for providing access to its medicines in less developed healthcare systems. PV: What is your vision for the Access to Medicines Initiative? Torres: We wanted to expand ou...
By Isabel Torres • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
mHealth in Clinical Research
Mobile technology could revolutionize clinical research. Sensors, wearable devices, and mobile apps have the potential to offer pharmaceutical sponsors access to patient data that complement existing data and provide a more complete view of safety and efficacy. The number of U.S. consumers who us...
By Denise Myshko • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
The Specialty Drug Market
As specialty drugs continue to earn a greater share of the pharmaceutical market, marketing, sales, and key opinion leader (KOL) professionals are faced with addressing market access issues, while needing to create an attractive value proposition for physicians. Going forward, these roles will e...
By Robin Robinson • Oct. 1, 2016 -
PharmaVoice Team/PharmaVoice
Advertising to the Masses
Earlier this year, eMarketer predicted that digital ad spending across all industries would surpass TV for the first time in 2017. Overall, TV ad spending will total $72.01 billion, or 35.8% of total media ad spending; digital ad spending in 2017 will equal $77.37 billion, or 38.4% of total ad sp...
By Robin Robinson • Oct. 1, 2016
Previous
